PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
12-Sep-2023 OpenFold AI Research Consortium Welcomes Three New Members: UCB, NVIDIA and Valence Labs Businesswire
12-Sep-2023 Zura Bio Enters into Sponsored Research Agreement with Benaroya Research Institute Businesswire
12-Sep-2023 Confo Therapeutics Appoints Stephen Dowd as Chief Business Officer Businesswire
12-Sep-2023 CureVac Advances Seasonal Flu Study to Phase 2 in Collaboration with GSK Following Selection of Promising mRNA Vaccine Candidate with Broad Coverage CureVac
12-Sep-2023 Newest Release of Titian Software’s Mosaic Sample Management Platform Enhances Sample Logistics Businesswire
12-Sep-2023 Six-Year Outcomes from Phase 3 CheckMate -227 Trial Show Durable, Long-Term Survival with Opdivo (nivolumab) Plus Yervoy (ipilimumab) in the First-Line Treatment of Patients with Metastatic Non-Small Cell Lung Cancer Bristol Myers Squibb
12-Sep-2023 Cingulate Announces Pricing of $4.0 Million Public Offering Cingulate
12-Sep-2023 RS Oncology Announces Completion of First-in-Human Phase 1 Clinical Trial of RSO-021, a Novel Irreversible Inhibitor of Mitochondrial PRX3 Businesswire
12-Sep-2023 Fasenra met the primary endpoint in the MANDARA Phase III trial in eosinophilic granulomatosis with polyangiitis (EGPA) AstraZeneca
12-Sep-2023 HUTCHMED Highlights Presentation of Results from the Phase IIIb Trial of Savolitinib at the 2023 World Conference of Lung Cancer HUTCHMED
12-Sep-2023 Critical agreement paves way for new model to accelerate access to important antibiotics for serious bacterial infections The Global Antibiotic Research & Development Partnership (GARDP) / Orchid Pharma Ltd (Orchid)
12-Sep-2023 MaaT Pharma and Skyepharma Complete Construction of Europe’s Largest Manufacturing Facility for Microbiome Ecosystem Therapies Businesswire
12-Sep-2023 MaaT Pharma and Skyepharma Complete Construction of Europe’s Largest Manufacturing Facility for Microbiome Ecosystem Therapies Businesswire
12-Sep-2023 AlgoTx Announces First Patients Dosed in US and European Arms of Phase II Clinical Trial of ATX01 in Rare Disease Erythromelalgia AlgoTherapeutix (AlgoTx)
12-Sep-2023 Kromek detectors used in Spectrum Dynamics’ new SPECT/CT scanner Kromek Group plc
12-Sep-2023 HUTCHMED Completes Patient Enrollment of a Bridging Study of Tazemetostat in Patients with Relapsed/Refractory Follicular Lymphoma in China HUTCHMED
12-Sep-2023 Sosei Heptares’ partner Neurocrine Biosciences Initiates Phase 1 Clinical Study Evaluating Effects of NBI-1117570 in Healthy Adults Sosei Group Corporation
12-Sep-2023 Clinical Trials in China: Unlocking the Potential of Advanced Therapies Presented by Novotech and Endpoints News Novotech
12-Sep-2023 Fertility Network responds to HFEA State of the Fertility Sector report Fertility Network
12-Sep-2023 Visual Components Robotics OLP launch enables digital production transformation Visual Components